Diatrizoic acid

From Wikipedia, the free encyclopedia

  (Redirected from Hypaque)
Jump to: navigation, search
Diatrizoic acid
Diatrizoic acid
IUPAC name
Identifiers
CAS number [737-31-5]
PubChem 2140
SMILES
ChemSpider ID 2055
Properties
Molecular formula C11H9I3N2O4
Molar mass 613.91 g mol−1
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox references

Diatrizoic acid (or its anionic form, Diatrizoate), also known as amidotrizoic acid, or 3,5-Diacetamido-2,4,6-triiodobenzoic acid, is a radiocontrast agent containing iodine.

Diatrizoate is considered a high-osmolality contrast agent. Its osmolality ranges from approximately 1500 mOsm/kg (50% solution)[1] to over 2000 mOsm/kg (76% solution).[2] Because it is a hypertonic solution, it should be avoided in imaging studies of the upper gastrointestinal tract in patients who are at risk of aspiration, as it will cause prompt pulmonary edema if accidentally introduced into the tracheobronchial tree.

Contents

[edit] Indications

Diatrizoic acid may be used as an alternative to barium sulfate for medical imaging of the gastrointestinal tract. It is indicated for use in patients who are allergic to barium, or in cases where the barium might leak into the abdominal cavity. It does not coat the stomach/bowel lining as well as barium, thus it is not used commonly for this purpose. In CT imaging water may be used as often.

It is also used to kill tapeworms.

[edit] Administration

[edit] Contraindications

A history of sensitivity to iodine is not a contraindication to using diatrizoate, although it suggests caution in use of the agent. In this case, an alternative such as barium sulfate may be preferable.

[edit] References

  1. ^ Amersham Health (April 2006). "Hypaque sodium (Diatrizoate Sodium) injection, solution. Product label". DailyMed. U.S. National Library of Medicine. http://dailymed.nlm.nih.gov/dailymed/fdaDrugXsl.cfm?id=1808&type=display. Retrieved on 2007-03-29. 
  2. ^ Amersham Health (April 2006). "Hypaque (Diatrizoate Meglumine and Diatrizoate Sodium) injection, solution. Product label". DailyMed. U.S. National Library of Medicine. http://dailymed.nlm.nih.gov/dailymed/fdaDrugXsl.cfm?id=997&type=display. Retrieved on 2007-03-29. 


Personal tools
Languages